Posted on: 06-Feb-2025
The FDA approved Symvess as a vascular conduit for extremity arterial injuries in adults when urgent revascularization is needed to avoid limb loss, and an autologous vein graft is not feasible, according to a press release.
Read More
Source: Healio
